Board Meeting25 Mar 2026, 10:00 am
Trading Window Closure Announced by Kilitch Drugs India Ltd Until After Q4 Results
AI Summary
Kilitch Drugs India Ltd has announced the closure of the trading window for all designated persons and their immediate relatives, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure will be effective from Wednesday, 1% April, 2026 until 48 hours after the declaration of the financial results for the quarter and year ended 31% March, 2026. The date of the board meeting to approve the audited financial results will be intimated in due course.
Key Highlights
- Kilitch Drugs India Ltd announces closure of trading window for designated persons and their immediate relatives.
- Closure effective from Wednesday, 1% April, 2026 until 48 hours after Q4 results declaration.
- Trading window closure in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
- The date of the board meeting to approve the audited financial results will be informed later.
- The announcement was made by Mukund Prataprai Mehta, Managing Director of Kilitch Drugs India Ltd.
Price Impact
More from KILITCH